20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma

Glioblastoma multiforme (GBM) is one of the most malignant human intracranial tumors. Temozolomide (TMZ) is the primary alkylating agent for GBM patients. However, many GBM patients are resistant to TMZ. Therefore, patients with GBM urgently need more effective therapeutic options. 20(S)‐ginsenoside...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zheng, Wei, Xiangyu, Shen, Lin, Zhu, Hanshuo, Zheng, Xuesheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317960/
https://www.ncbi.nlm.nih.gov/pubmed/30431207
http://dx.doi.org/10.1111/cas.13881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317960/
https://www.ncbi.nlm.nih.gov/pubmed/30431207
http://dx.doi.org/10.1111/cas.13881

Ejemplares similares